Working... Menu

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02035514
Recruitment Status : Completed
First Posted : January 14, 2014
Last Update Posted : December 15, 2016
Ministerio de Sanidad, Servicios Sociales e Igualdad
Information provided by (Responsible Party):
Cristina Ramo, Germans Trias i Pujol Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2016
  Actual Study Completion Date : July 2016